IMcoMET is a MedTech startup, offering a new source of biomarkers through their M-Duo Technology®. This innovation allows access and control of interstitial fluid, providing valuable biomarkers for assessing tissue condition and overall health. With a focus on improving skin cancer diagnostics and research, IMcoMET drives personalized medicine and biomedical research to enhance therapy outcomes for skin cancer patients. Founded in 2018, IMcoMET operates in the Biopharma, Biotechnology, and Pharmaceutical industries.
IMcoMET
Access a new source of biomarkers
Founded 2018
The Netherlands
4 employees
Biopharma, Biotechnology +1
The Netherlands
4 employees
Biopharma, Biotechnology +1
General Information
Get notified when IMcoMET moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track IMcoMET
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
The Netherlands Market
Biopharma
About IMcoMET
Taxonomy: MedTech, biomarker technology, M-Duo Technology®, fluid analysis, cancer diagnostics, personalized medicine, biomedical research, therapy outcomes, skin cancer, interstitial fluid, biomarker analysis, diagnostic tools, oncology research, precision medicine
No funding data available for IMcoMET yet.
Get notified when IMcoMET raises fundingIMcoMET Alternatives & Competitors
IMcoMET vs
Pioneering early cancer diagnosis through advanced fluid biopsy technology
Series A
11-50 employees
Biotechnology, Health Care
IMcoMET vs
Melanoma and Skin Cancer Trials
Australia
Conquering melanoma and skin cancer through clinical trials.
16 employees
IMcoMET vs
FAQ About IMcoMET
Access a new source of biomarkers
IMcoMET was founded in 2018.
IMcoMET is headquartered in The Netherlands.
IMcoMET operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
IMcoMET has approximately 4 employees.
Top alternatives and competitors to IMcoMET include ARNA Genomics, Melanoma and Skin Cancer Trials, ASC Oncology GmbH, Geneseeq Technology Inc., SWOG Cancer Research Network. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IMcoMET and ARNA Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors IMcoMET and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.